Archive
News & Updates.
Product news, regulatory milestones, published clinical evidence, and longer-form writing from the Pill Connect team.
2026
2 entries
-
The AI Adherence Trap: Better Data, Not Fewer Humans
A blog on: The adherence data quality problem, The risks of AI-driven coaching, What responsible AI actually looks like
-
Blog: Medication Adherence in Rare Disease Trials: Listening Beyond the Data
Medication adherence in rare disease clinical trials is complex and deeply human. This blog examines the limitations of retrospective adherence data and how real-time visibility can improve patient support and trial outcomes.
2025
4 entries
-
Pill Connect Dispenser achieves CE mark
We're pleased to announce that the newest Pill Connect dispenser has achieved CE mark for radio and electrical safety.
-
Phase 2A Adherence Monitoring
Aardex Group and Pill Connect partner to advance dose selection in clinical trial
-
Pill Connect's new dispenser passes ISO8317 CRSF Testing
This certification is another vital step in ensuring that game changing innovation remains compliant with industry trusted standards, giving patients and provides peace of mind.
-
Pill Connect secures new funding to scale
A Manchester-based medtech company has secured funding from the GMC Life Sciences Fund by Praetura, and through NPIF II — Praetura Equity Finance, to continue scaling its reusable digital device.
2024
5 entries
-
Pill Connect attending the World Adherence Forum 2024
The World Adherence Forum of the EU COST action ENABLE (ENABLE Adherence), is taking place in Brussels. Chaired by Job van Boven of the University of Groningen, the action has, over the past 4 years, brought hundreds of collaborators together to tackle the challenge of low medicine adherence affecting treatment outcomes by leveraging digital innovations.
-
Pill Connect featured in Greater Manchester's 30 One's to Watch list
Pill Connect is featured in BusinessCloud's 'Ones to Watch' in their inaugural 'GM 125 Rising Stars of Business' list.
-
Pill Connect expanding its dose monitoring system to SaMD
Taking precision from the clinic to the pharmacy: Pill Connect to expand its dose monitoring system to SaMD
-
Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes
Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO's (Contract development and manufacturing organization) smart packaging supply program.
-
PharmaPack 2024
Pill Connect to showcase their real-time, adherence tracking technology at PharmaPack 2024 StartUp Hub
2023
4 entries
-
Connecting quality accreditations with our smart dosing device
We are delighted to announce a series of quality accreditations which reaffirm the market readiness of our smart dosing device.
-
Pill Connect is certified to ISO9001
Pill Connect successfully passed its ISO9001 audit conducted by SGS.
-
Patent granted in EPO
Pill Connect patent EP3566688 has been granted by the EPO, adding to the previous grants in the US and JPN.
-
Addressing Adherence Challenges in Clinical Trials
Article published in PMPS co-authored with Bernard Vrijens and Job van Boven.
2022
3 entries
-
Successful TB clinical trial results published in ERJ
Pill Connect dispenser supports clinical trial for personalised Tuberculosis care
-
Pill Connect raises investment
Pill Connect has closed an investment round to support the commercial launch of their Smart Dispenser
-
Smart Dispenser tested in pharma pilot
Pill Connect releases adherence data to demonstrate efficacy of smart dosing technology
2021
2 entries
